Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events

• Unité de recherche: INNOSUISSE
• Numéro de projet: 10901.1;4 PFLS-LS
• Titre du projet anglais: Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events

Description succincte (Allemand)

Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events

Description succincte (Anglais)

Qstent - Development of a novel coronary stent technology for rapid endothelialization and reduction of adverse cardiac events

Résumé des résultats (Abstract) (Allemand)

Development of a clinically superior alternative to today's available coronary artery stents: Qvanteq's Qstent is based on a surface modification of 'bare metal stents' and is expected to accelerate in-growth, which is generally believed to minimize the early and also late adverse cardiac events (i.e. heart attacks) that are associated with today's available 'bare metal stents' as well as 'drug-eluting stents'.